Literature DB >> 6068921

Hypercalcemia of malignant disease.

.   

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California Medical Center, San Francisco. Taken from transcriptions, they are prepared by Drs. Martin J. Cline and Hibbard E. Williams, Assistant Professors of Medicine, under the direction of Dr. Lloyd H. Smith, Jr., Professor of Medicine and Chairman of the Department of Medicine.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6068921      PMCID: PMC1502861     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  5 in total

Review 1.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

2.  Skeletal metastases and mammary cancer.

Authors:  C S Galasko
Journal:  Ann R Coll Surg Engl       Date:  1972-01       Impact factor: 1.891

3.  Hypercalcaemia in carcinoma of the breast.

Authors:  C S Galasko
Journal:  Proc R Soc Med       Date:  1969-05

4.  Mithramycin for hypercalcemia of malignant disease.

Authors:  T E Godfrey
Journal:  Calif Med       Date:  1971-10

5.  Hypercalcaemia in patients with advanced mammary cancer.

Authors:  C S Galasko; J I Burn
Journal:  Br Med J       Date:  1971-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.